Related Experiment Video
Updated: Jan 5, 2026

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
Ginsenoside Rg3 regulates DNA damage in non-small cell lung cancer cells by activating VRK1/P53BP1 pathway
Tianhua Liu1, Ling Zuo1, Dongqing Guo2
1School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Abstract:
Lung cancer is the leading cause of cancer-related deaths. Ginsenoside Rg3 is the main ingredient of Ginseng which is used to treat non-small cell lung cancer (NSCLC). It has been found to enhance the efficiency of chemotherapy thereby reducing its side effects. Previous studies found that ginsenoside Rg3 can reduce the occurrence of NSCLC by inducing DNA damage. Yet, its anti-DNA damaging effects and mechanisms in tumor cells are still not fully understood. This study explored the effect of ginsenoside Rg3 on DNA repair and VRK1/P53BP1 signaling pathway. Ginsenoside Rg3 treatment significantly decreased the incidence and invasionin a mouse model of lung cancer induced by urethane. The results of cell survival assay and single cell gel electrophoresis showed that ginsenoside Rg3 protected lung adenocarcinoma cells from DNA damage as well as inhibited the proliferation of tumor cells. Ginsenoside Rg3 increased the mRNA and protein expression of VRK1 in NSCLC cells as measured by RT-qPCR and western blot, respectively. These findings suggests that ginsenoside Rg3 regulates VRK1 signaling. Immunofluorescence assays showed that P53BP1 and VRK1 protein level increased, and the VRK1 protein translocated between the nuclei and cytoplasm. Finally, this conclusion was confirmed by the reverse validation in VRK1-knockdown cells. Taken together, these results show that ginsenoside Rg3 upregulate VRK1 expression and P53BP1 foci formation in response to DNA damage thereby inhibiting the tumorigenesis and viability of cancer cells. These findings reveal the role of Rg3 in lung cancer and provides therapeutic targets for developing new drugs in the prevention and treatment of lung cancer.
Insights
Ginsenoside Rg3 protects lung cancer cells from DNA damage and inhibits tumor growth by upregulating VRK1 expression and P53BP1 foci formation. This reveals new therapeutic targets for lung cancer prevention and treatment.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Lung cancer is a leading cause of cancer-related mortality.
- Ginsenoside Rg3, derived from Ginseng, shows promise in treating non-small cell lung cancer (NSCLC).
- Previous research indicates Rg3 may induce DNA damage to combat NSCLC, but its anti-DNA damaging effects and mechanisms require further elucidation.
Purpose of the Study:
- To investigate the effects of Ginsenoside Rg3 on DNA repair mechanisms in lung cancer.
- To explore the role of the VRK1/P53BP1 signaling pathway in Ginsenoside Rg3's anti-cancer activity.
- To understand the anti-tumorigenic mechanisms of Ginsenoside Rg3 in NSCLC.
Main Methods:
- Utilized a mouse model of urethane-induced lung cancer.
- Performed cell survival assays and single-cell gel electrophoresis to assess DNA damage and cell viability.
- Quantified VRK1 mRNA and protein expression using RT-qPCR and Western blot.
- Employed immunofluorescence assays to observe VRK1 and P53BP1 protein localization.
- Conducted experiments with VRK1-knockdown cells for validation.
Main Results:
- Ginsenoside Rg3 treatment reduced lung cancer incidence and invasion in vivo.
- Rg3 protected lung adenocarcinoma cells from DNA damage and inhibited proliferation in vitro.
- Rg3 significantly increased VRK1 mRNA and protein expression in NSCLC cells.
- Observed increased P53BP1 foci formation and VRK1 nuclear-cytoplasmic translocation.
- VRK1 knockdown reversed the protective effects of Rg3, confirming its role.
Conclusions:
- Ginsenoside Rg3 upregulates VRK1 expression and promotes P53BP1 foci formation in response to DNA damage.
- These actions inhibit lung cancer cell tumorigenesis and viability.
- Rg3's mechanism involves regulating the VRK1/P53BP1 pathway, offering potential therapeutic targets for lung cancer.
Related Concept Videos
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...